Cite
Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up.
MLA
van Campenhout, Margo J. H., et al. “Long‐term Follow‐up of Patients Treated with Entecavir and Peginterferon Add‐on Therapy for HBeAg‐positive Chronic Hepatitis B Infection: ARES Long‐term Follow‐up.” Journal of Viral Hepatitis, vol. 26, no. 1, Jan. 2019, pp. 109–17. EBSCOhost, https://doi.org/10.1111/jvh.12997.
APA
van Campenhout, M. J. H., Brouwer, W. P., Xie, Q., Guo, S., Chi, H., Qi, X., Tabak, F., Streinu, C. A., Wang, J., Zhang, N., Idilman, R., Reesink, H. W., Diculescu, M., Simon, K., Akdogan, M., Mazur, W., de Knegt, R. J., Verhey, E., Hansen, B. E., & Janssen, H. L. A. (2019). Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up. Journal of Viral Hepatitis, 26(1), 109–117. https://doi.org/10.1111/jvh.12997
Chicago
van Campenhout, Margo J. H., Willem Pieter Brouwer, Qing Xie, S. Guo, Heng Chi, Xun Qi, Fehmi Tabak, et al. 2019. “Long‐term Follow‐up of Patients Treated with Entecavir and Peginterferon Add‐on Therapy for HBeAg‐positive Chronic Hepatitis B Infection: ARES Long‐term Follow‐up.” Journal of Viral Hepatitis 26 (1): 109–17. doi:10.1111/jvh.12997.